Table 1 Demographic and clinical characteristics of samples.

From: Different responses to risperidone treatment in Schizophrenia: a multicenter genome-wide association and whole exome sequencing joint study

Variables

Responders Group

Nonresponders Group

t/X2

P value

Age, mean (SD)

36.40 (10.621)

38.48 (12.205)

−1.197

0.233

Sex

Male, No. (%)

38 (57.6)

84 (52.5)

0.485

0.486

Female, No. (%)

28 (42.4)

76 (47.5)

  

Clinical assessment, mean (SD)

Baseline PANSS total scores

80.70 (16.423)

85.74 (14.466)

−2.295

0.023

Endpoint PANSS total scores

35.73 (4.056)

51.43 (9.856)

−12.509

0.000

PANSS percentage changes

89.749 (6.322)

61.81 (12.050)

17.853

0.000

  1. PANSS positive and negative syndrome scale.